The University of Southampton
University of Southampton Institutional Repository

Statins as modulators of bone formation

Statins as modulators of bone formation
Statins as modulators of bone formation
The use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) to reduce serum cholesterol is well described. However, the recent finding that statins have direct effects on bone was unexpected. A number of epidemiological studies have recently been published that explore the effects of statins on bone mineral density and risk of fracture in humans. Statins may act by directly stimulating the expression of bone morphogenetic protein-2 and increasing osteoblast differentiation or, like nitrogen-containing bisphosphonates, may have effects on the mevalonate pathway that leads to inhibition of osteoclast activity and osteoblast apoptosis. In addition, the demonstration that statins can inhibit inflammation and encourage angiogenesis offers other possibilities for action.
angiogenesis, bone morphogenetic proteins, fracture, inflammation, statins
1465-9905
151-153
Edwards, Christopher J.
dcb27fec-75ea-4575-a844-3588bcf14106
Spector, Tim D.
1e47066c-6620-4f86-af6f-89d9e130ffc2
Edwards, Christopher J.
dcb27fec-75ea-4575-a844-3588bcf14106
Spector, Tim D.
1e47066c-6620-4f86-af6f-89d9e130ffc2

Edwards, Christopher J. and Spector, Tim D. (2002) Statins as modulators of bone formation. Arthritis Research, 4 (3), 151-153. (doi:10.1186/ar399).

Record type: Article

Abstract

The use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) to reduce serum cholesterol is well described. However, the recent finding that statins have direct effects on bone was unexpected. A number of epidemiological studies have recently been published that explore the effects of statins on bone mineral density and risk of fracture in humans. Statins may act by directly stimulating the expression of bone morphogenetic protein-2 and increasing osteoblast differentiation or, like nitrogen-containing bisphosphonates, may have effects on the mevalonate pathway that leads to inhibition of osteoclast activity and osteoblast apoptosis. In addition, the demonstration that statins can inhibit inflammation and encourage angiogenesis offers other possibilities for action.

Full text not available from this repository.

More information

Published date: 2002
Additional Information: Commentary
Keywords: angiogenesis, bone morphogenetic proteins, fracture, inflammation, statins

Identifiers

Local EPrints ID: 25434
URI: http://eprints.soton.ac.uk/id/eprint/25434
ISSN: 1465-9905
PURE UUID: 994f0676-852c-457e-a338-cf5644f0edd1

Catalogue record

Date deposited: 06 Apr 2006
Last modified: 15 Jul 2019 19:16

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×